Lipnitskiĭ E M, Isakova O V, Movchun V A, Apdatskaia M D
Vestn Ross Akad Med Nauk. 2011(1):7-11.
Results of evaluation of the efficiency of myotropic spasmolytic Duspatalin during long-term therapy and preventive treatment of functional post-cholecystectomy syndrome are presented. The influence of the treatment on manifestations of clinical symptoms, quality of a life estimated based on a visual-analog scale, and intestinal microbiocenosis (changes in the activity of short-chain fatty acids) are discussed.
本文展示了在长期治疗和预防性治疗功能性胆囊切除术后综合征期间，对肌动解痉药杜斯帕他林疗效的评估结果。讨论了该治疗对临床症状表现、基于视觉模拟量表评估的生活质量以及肠道微生物群落（短链脂肪酸活性变化）的影响。
